European regulators initially said in July that the drug's benefits did not outweigh its risks. View on euronews ...

A multitude of genes have been linked to the development of Alzheimer's disease. Specifically how those genes might influence ...

The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

Using cerebrospinal fluid, researchers have identified proteins and genes linked to Alzheimer's progression that could form ...

While growing evidence suggests that there’s a link between blood iron levels and the development of Alzheimer’s disease, new ...

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...

The European Medicines Agency said Thursday that its committee evaluating medical products has recommended partial approval ...

Popular Diabetes and Weight-Loss Drug May Reduce Risk of ... have been shown to correlate with heightened risk for Alzheimer's disease. A new study might explain ... Oct. 10, 2024 — A new ...

Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...